Edward N. Libby, MD
Before he became a physician, Edward Libby wanted to make music. "After a few years as a teenager pursuing music, I realized that I simply was nowhere near talented enough…..so I went to college."
Libby started out in college hoping to go to nursing school. (His mother was a registered nurse). "One summer in college (I had almost accumulated enough college credits to transfer into the University of Texas at El Paso Hotel Dieu Hospital School of Nursing)… I was permitted to observe surgery at the local teaching hospital for several weeks. From the first moment I saw surgeons cutting with a scalpel, I knew I had to be a doctor. It was simply too exciting to miss out on!”
It was during his fellowship that Dr. Libby realized that oncology doctors often have unique and deep relationships with their patients and that they are close with almost all of their patients.. “We are happy when there is good news and we cry when things aren’t going well,” he says. “The combination of science, art, and humanism in medicine is in my opinion, best exemplified in oncology.”
Libby joined SCCA to advance his clinical research career. “Combining research with patient care is what gets me up in the morning and makes me excited about going to work,” he says. “Scientific research studies are absolutely critical if we are to advance the treatment of patients with cancer. The goal(s) of clinical research studies are to cure more patients or to prolong patients' lives when cures are not possible (that is make cancer a chronic disease), to reduce the side effects of treatment, and to preserve the quality of patients' lives.”
His research interests are to find new treatments for blood cancers, in particular, multiple myeloma, Waldenstrom's macroglobulinemia, amyloidosis, and the indolent lymphomas. "My hope is to participate (with my patients and colleagues) in the discovery and application of new drugs for patients with these diseases.
The opportunity to participate in and lead clinical research at SCCA is outstanding, according to Libby. He is involved in all types of clinical research in particular that involving new and improved treatments for patients with newly diagnosed and relapsed and refractory patients with multiple myeloma, Waldenstrom's macroglobulinemia, amyloidosis, and the indolent lymphomas.
"My research groups are actively studying new drugs, new combinations of drugs, and new diagnostic techniques for patients with blood cancers," he says.
These examples of progress are already occurring in many cancers.
"I am fortunate to be working exclusively in the specialty area of hematologic malignancies (blood cancers) because some of the most important and groundbreaking advances in the treatment of all patients with cancer are based on initial research breakthroughs produced for patients with blood cancers" he says.
Outside of work, Libby enjoys a little bit of everything. "Jogging, going to the gym, music, and art," he says. "The sports scene in Seattle is terrific and I have attended many Mariners, Sounders, and Seahawk games. I plan to see the Huskies play this season, too. Also, I've picked up sailing since arriving in Seattle and joined a sailboat club on Puget Sound." Family and friends are very important to Dr. Libby and so he tries to spend as much time as possible with his kids "and my close compadres….that's Spanish for friends,” he says.
Edward N. Libby, MDDr. Libby is a hematologist/oncologist who cares for patients who have multiple myeloma, Waldenstrom's macroglobulinemia, amyloidosis, and indolent lymphomas.
Patient Care Philosophy:
Get to know your patient and their family. Listen, listen, and then listen some more to what your patient has to say. We are taking this journey together. Focus on being “there” for your patients. Humility is key.
Thomas Merton wrote…..”Pride makes us artificial and humility makes us real.”
- Associate Professor, Medical Oncology Division, University of Washington School of Medicine
- Associate Member, Clinical research Division, Fred Hutchinson Cancer Research Center
Multiple Myeloma, Plasma cell Leukemia, Amyloidosis, Waldenstrom’s macroglobulinemia, lymphoma, hematologic malignancies
Education And Training
- The University of Texas Medical School at Houston, 1984
- Residency and Chief Residency: University of New Mexico School of Medicine, 1984-88
- Fellowship: University of New Mexico Cancer Center, 2002-2005